Mistake 3: Confusing U-100 with U-40 syringes
*In a 68-week double-blind trial studying once-weekly semaglutide injections (2.4 mg) in 1,961 patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15%, when paired with diet and exercise changes
The most commonly reported side effects in clinical trials include dry mouth, insomnia, increased heart rate, constipation, and headache
Additionally, the peptide stability profile may differ in saline solutions
Join over 50,000 patients who trust Hi-Doctor, reflected in our 4.8 Trustpilot rating
Start your intake How GLP-1 Dosing Intervals Work and Why Timing Matters GLP-1 medications like semaglutide and tirzepatide work through weekly injections designed to maintain consistent hormone levels throughout seven days